Adherence to buprenorphine-XR through hybrid telehealth contingency management procedures: a case series

• Published in: Journal of substance use Vol. 2024; pp. 1 - 6
• Main Authors: Gorman, Jay A, Lindvig-Springborn, Alexandria, Lee, Jonathan, Khazanov, Gabriela K, DePhilippis, Dominick
• Format: Journal Article
• Language: English
• Published: England 09-05-2024
• Subjects: Opioid use disorder; contingency management; treatment adherence
• ISSN: 1465-9891; 1475-9942
• DOI: 10.1080/14659891.2024.2351019

Contingency management (CM) for substance use disorders (SUD) is effective in strengthening recovery behaviors, however can be quite burdensome. When health facilities experience staff shortages, adapting current CM protocols to be less staff and time intensive may be one way to address this challenge.
Case series (N = 3).
Three veterans with opioid use disorder (OUD) received CM for treatment adherence through a Veteran Health Administration Outpatient Substance Disorder program. Due to the COVID-19 pandemic, traditional CM procedures resulted in limited accessibility and staff, delayed appointments, and decreased patient satisfaction. In response, the hybrid telehealth contingency management (HTCM) procedure was developed and implemented. Flexibility offered by HTCM allowed for consecutive completion of appointments and maintained adherence to BUP-XR treatment.
This is a novel method of CM implementation. HTCM streamlined the process and was successful in increasing accessibility, reducing time-burden on patients and staff, while preserving fidelity to key components of the model. Considerations for future implementation and implications of HTCM are discussed.